Cover Image
Market Research Report

Healthcare, Regulatory and Reimbursement Landscape Russia

Published by GlobalData Product code 244981
Published Content info 178 Pages
Immediate Delivery Available
Price
Back to Top
Healthcare, Regulatory and Reimbursement Landscape Russia
Published: June 18, 2012 Content info: 178 Pages
Comment
Country specific reports on the topic are available for purchase. Please contact us.
Description

Summary

GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Russia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

Russia's population decreased at a CAGR of 0.1% between 2005 and 2010. As in most developed countries, the population contains a high proportion of elderly people, with approximately 13.2% of the population above the age of 65 years in 2010. The disease burden associated with this large elderly population is expected to boost growth in the pharmaceutical market, although hinder growth in the economy at the same time. Russia's pharmaceutical market is one of the fastest growing markets in the world, and was valued at approximately $18.7 billion in 2010, having grown at a CAGR of 23% from 2005. The medical device market is one of the most stable industries in the healthcare sector. The main segments in 2010 were diagnostic imaging, ophthalmic devices, cardiovascular devices, in vitro diagnostics and diabetes care devices.

The positive trends in the healthcare market can be attributed primarily to -

  • Large elderly population
  • Increased government spending
  • Government initiatives focusing on the prevention and management of chronic diseases
  • Government efforts to simplify regulatory guidelines
  • Increased prevalence of non-communicable diseases

Scope

The report provides information on the healthcare, regulatory and reimbursement landscape, and its scope includes -

  • Overview of the pharmaceutical and medical devices markets, including size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analysis of the major players in the pharmaceutical and medical device markets.
  • Insightful review of the reimbursement and regulatory landscape, including details of the reimbursement process, regulatory agencies, and approval processes for new drugs and medical devices.
  • A detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the healthcare market.

Reasons to buy

The report comprehensively covers both the pharmaceutical and the medical device markets. It will enhance your decision-making capability and allow you to -

  • Develop business strategies by understanding the trends shaping and driving the healthcare market in Russia.
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, and pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of the main competitors.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnerships.
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market.
Table of Contents
Product Code: GDHC0018CHR

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Report Guidance

3. Overview of the Pharmaceutical and Medical Device Market

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Supply Channels
    • 3.1.3. Market Segments
    • 3.1.4. Major Therapeutic Areas
    • 3.1.5. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
    • 3.2.2. Overview of Top Five Segments
    • 3.2.3. Major Players
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share in Healthcare Spending
    • 4.1.5. Drug Price Trends
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. New Drug Approval Process
    • 4.2.3. New Device Approval Process
    • 4.2.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.5. Licensing Process for Pharmaceutical Exports and Imports
    • 4.2.6. Intellectual Property Rights
    • 4.2.7. Clinical Trial Regulations
    • 4.2.8. Pharmaceutical Advertising Regulations
    • 4.2.9. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. Government Structural Balance
    • 5.3.9. Government Gross Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.1. Healthcare Facilities
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Major Components of Healthcare Spending
    • 5.6.3. Share of Public and Private Sectors
    • 5.6.4. Spending on Pharmaceutical R&D
  • 5.7. Trade Associations
    • 5.7.1. Association of Russian Pharmaceutical Manufacturers
    • 5.7.2. Association of International Pharmaceutical Manufacturers
    • 5.7.3. Russian Association of Pharmaceutical Marketing
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasting
    • 7.3.4. Primary Research
    • 7.3.5. Expert Panel Validation
  • 7.4. Contact Us
  • 7.5. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market ($bn), Russia, 2005-2010
  • Table 2: Pharmaceutical Market ($bn), Russia, Forecast, 2011-2020
  • Table 3: Sources of Pharmaceuticals, Russia, Share (%), 2008-2010
  • Table 4: Innovative and Generic Products, Russia, Market Share (%), 2007
  • Table 5: Wholesaler Mark-ups (%), Various Countries, 2008
  • Table 6: Cardiovascular Disease, Russia, Economic Burden ($bn), 2005-2010
  • Table 7: Structure of Economic Burden of Cardiovascular Disease, Russia, Share (%), 2009
  • Table 8: Causes of Mortality among People with Type 1 Diabetes, Russia, 2007
  • Table 9: Causes of Mortality among People with Type 2 Diabetes, Russia, 2007
  • Table 10: Patients with Mental and Behavior Disorders (Per 100,000 Population), Russia, 2010
  • Table 11: Major Products, Novartis, Global, Revenue ($m), 2011
  • Table 12: Planned Filings, Novartis, 2012 to ≥ 2016
  • Table 13: Major Products, Pharmstandard, Revenue ($m), 2011
  • Table 14: Major Products, Bayer AG, Global, Revenue ($m), 2011
  • Table 15: Late-stage Pipeline, Bayer AG, 2011
  • Table 16: Major Products, Servier, 2011
  • Table 17: Major Products, Berlin-Chemie/Menarini, 2011
  • Table 18: Pipeline, Menarini, 2011
  • Table 19: Medical Device Market ($bn), Russia, 2005-2010
  • Table 20: Medical Device Market ($bn), Russia, Forecast, 2011-2020
  • Table 21: Medical Device Market, Russia, Segment Share (%), 2010
  • Table 22: Diagnostic Imaging Market ($m), Russia, 2005-2010
  • Table 23: Sales Trends for Major Players*, Diagnostic Devices, Russia, 2005-2010
  • Table 24: Ophthalmic Devices Market ($m), Russia, 2005-2010
  • Table 25: Sales Trends for Major Players*, Ophthalmic Devices, Russia, 2010
  • Table 26: Cardiovascular Devices Market ($m), Russia, 2005-2010
  • Table 27: Sales Trends for Major Players*, Cardiovascular Devices, Russia, 2010
  • Table 28: In Vitro Diagnostics Market ($m), Russia, 2005-2010
  • Table 29: Sales Trends for Major Players*, In Vitro Diagnostics, Russia, 2010
  • Table 30: Diabetes Care Devices Market ($m), Russia, 2005-2010
  • Table 31: Sales Trends for Major Players*, Diabetes Care Devices, Russia, 2010
  • Table 32: Major Medical Device Companies, Russia, Revenue ($m), 2010
  • Table 33: Major Products, Medtronic, Global, Revenue ($m), 2011
  • Table 34: Major Products, Siemens, Global, Revenue ($m), 2012
  • Table 35: Major Products, Philips Healthcare, 2012
  • Table 36: Reimbursement Drug Lists, Russia, 2011
  • Table 37: Healthcare Spending, Russia, Patient Share (%), 2005-2010
  • Table 38: Medical Equipment Classification, Russia, 2011
  • Table 39: GDP Per Capita ($), Russia, 2005-2010
  • Table 40: GDP Per Capita ($), Russia, Forecast, 2011-2020
  • Table 41: GDP, Russia, Annual Growth (%), 2005-2010
  • Table 42: GDP, Russia, Annual Growth (%), Forecast, 2011-2020
  • Table 43: GNI Per Capita ($), Russia, 2005-2010
  • Table 44: Average Consumer Price Index, Russia, 2005-2010
  • Table 45: Consumer Price, Russia, Annual Change (%), 2005-2010
  • Table 46: Average Consumer Price, Russia, Annual Change (%), Forecast, 2011-2020
  • Table 47: Currency Exchange Rate (RUB/$), Russia, 2005-2010
  • Table 48: Foreign Direct Investment ($bn), Russia, 2005-2010
  • Table 49: Foreign Exchange Reserves ($bn), Russia, 2005-2010
  • Table 50: Imports ($bn), Russia, 2005-2010
  • Table 51: Exports ($bn), Russia, 2005-2010
  • Table 52: General Government Structural Balance ($bn), Russia, 2005-2010
  • Table 53: General Government Structural Balance ($bn), Russia, 2011-2020
  • Table 54: General Government Gross Debt ($bn), Russia, 2005-2010
  • Table 55: General Government Gross Debt ($bn), Russia, 2011-2020
  • Table 56: Major Industries, Russia, Production ($bn), 2010
  • Table 57: Population (m), Russia, 2005-2010
  • Table 58: Population (m), Russia, Forecast, 2011-2020
  • Table 59: Urban and Rural Population, Russia, Share (%), 2005-2010
  • Table 60: Urban and Rural Population, Russia, Share (%), Forecast, 2011-2020
  • Table 61: Age Groups, Russia, Population Distribution (%), 2005-2010
  • Table 62: Age Groups, Russia, Population Distribution (%), Forecast, 2011-2020
  • Table 63: Births (Per 1,000 Population), Russia, 2005-2010
  • Table 64: Births (Per 1,000 Population), Russia, Forecast, 2011-2020
  • Table 65: Mortality (Per 1,000 Population), Russia, 2005-2010
  • Table 66: Mortality (Per 1,000 Population), Russia, Forecast, 2011-2020
  • Table 67: Major Causes of Mortality ('000s), Russia, 2008
  • Table 68: Children <5 Years, Russia, Mortality (Per 1,000 Live Births), 2005-2010
  • Table 69: Immunization Rate (%), Russia, 2005-2010
  • Table 70: Major Causes of Male Mortality ('000s), Russia, 2008
  • Table 71: Major Causes of Female Mortality ('000s), Russia, 2008
  • Table 72: Gender Ratio (M/F), Russia, 2005-2010
  • Table 73: Life Expectancy at Birth (Years), Russia, 2005-2010
  • Table 74: Life Expectancy at Birth (Years), Russia, Forecast, 2011-2020
  • Table 75: Students ('000s), Russia, 2005-2010
  • Table 76: Unemployment Rate (%), Russia, 2005-2010
  • Table 77: Employees, Russia, Segment Share (%), 2008
  • Table 78: Major Diseases, Russia, Incidence ('000s), 2008
  • Table 79: Major Diseases, Russia, Disability-adjusted Life Years (Per 100,000 Population), 2004
  • Table 80: Hospitals, Russia, 2005-2010
  • Table 81: Out-patient Clinics, Russia, 2005-2010
  • Table 82: Out-patient Clinics, Russia, Urban-Rural, 2005-2010
  • Table 83: Dental Clinics, Russia, 2005-2010
  • Table 84: Public Hospitals, Russia, 2005-2010
  • Table 85: Private Hospitals, Russia, 2005-2010
  • Table 86: Hospital Beds by Specialization ('000s), Russia, 2010
  • Table 87: Beds (Per 1,000 Population), Russia, 2005-2010
  • Table 88: Physicians (Per 1,000 Population), Russia, 2005-2010
  • Table 89: Physicians by Specialization ('000s), Russia, 2010
  • Table 90: Deaths Attributed to the Environment (Per 100,000 Population), Russia, 2004
  • Table 91: Common Air Pollutants (Million Tons), Russia, 2005-2010
  • Table 92: PM10 (micrograms per cubic meter), Russia, 2005-2010
  • Table 93: CO2 Emissions (Million Tons), Russia, 2005-2010
  • Table 94: Organic Water Pollutant Emissions (Metric Tons Per Day), Russia, 2005-2010
  • Table 95: Healthcare Personnel, Russia, Share (%), 2010
  • Table 96: Healthcare Expenditure (% of GDP), Russia, 2005-2010
  • Table 97: Healthcare Expenditure (% of GDP), Russia, 2011-2020
  • Table 98: Healthcare Expenditure, Russia, Share of Major Components (%), 2007
  • Table 99: Healthcare Expenditure, Russia, Public-Private Share (%), 2005-2010
  • Table 100: Major Healthcare Trade Fairs, Russia

List of Figures

  • Figure 1: Pharmaceutical Market ($bn), Russia, 2005-2010
  • Figure 2: Pharmaceutical Market ($bn), Russia, Forecast, 2011-2020
  • Figure 3: Sources of Pharmaceuticals, Russia, Share (%), 2008-2010
  • Figure 4: Innovative and Generic Products, Russia, Market Share (%), 2007
  • Figure 5: Distribution Channels, Russia, 2011
  • Figure 6: Wholesaler Mark-ups (%), Various Countries, 2008
  • Figure 7: Cardiovascular Disease, Russia, Economic Burden ($bn), 2005-2010
  • Figure 8: Structure of Economic Burden of Cardiovascular Disease, Russia, Share (%), 2009
  • Figure 9: Causes of Mortality among People with Type 1 Diabetes, Russia, 2007
  • Figure 10: Causes of Mortality among People with Type 2 Diabetes, Russia, 2007
  • Figure 11: Patients with Mental and Behavior Disorders (Per 100,000 Population), Russia, 2010
  • Figure 12: Medical Device Market ($bn), Russia, 2005-2010
  • Figure 13: Medical Device Market ($bn), Russia, Forecast, 2011-2020
  • Figure 14: Medical Device Market, Russia, Segment Share (%), 2010
  • Figure 15: Diagnostic Imaging Market ($m), Russia, 2005-2010
  • Figure 16: Sales Trends for Major Players*, Diagnostic Devices, Russia, 2005-2010
  • Figure 17: Ophthalmic Devices Market ($m), Russia, 2005-2010
  • Figure 18: Sales Trends for Major Players*, Ophthalmic Devices, Russia, 2005-2010
  • Figure 19: Cardiovascular Devices Market ($m), Russia, 2005-2010
  • Figure 20: Sales Trends for Major Players*, Cardiovascular Devices, Russia, 2005-2010
  • Figure 21: In Vitro Diagnostics Market ($m), Russia, 2005-2010
  • Figure 22: Sales Trends for Major Players*, In Vitro Diagnostics, Russia, 2005-2010
  • Figure 23: Diabetes Care Devices Market ($m), Russia, 2005-2010
  • Figure 24: Sales Trends for Major Players*, Diabetes Care Devices, Russia, 2005-2010
  • Figure 25: Major Medical Device Companies, Russia, Revenue ($m), 2010
  • Figure 26: Drivers and Barriers, Healthcare Market, Russia, 2012
  • Figure 27: Organizational Structure of the Healthcare System, Russia, 2011
  • Figure 28: Health Service Financing, Russia, 2011
  • Figure 29: Inclusion Process for Reimbursement List, Russia, 2011
  • Figure 30: Healthcare Spending, Russia, Patient Share (%), 2005-2010
  • Figure 31: New Drug Approval Process, Russia, 2011
  • Figure 32: Political System, Russia, 2012
  • Figure 33: Pharma-2020 Strategy, Russia, 2009
  • Figure 34: GDP Per Capita ($), Russia, 2005-2010
  • Figure 35: GDP Per Capita ($), Russia, Forecast, 2011-2020
  • Figure 36: GDP, Russia, Annual Growth (%), 2005-2010
  • Figure 37: GDP, Russia, Annual Growth (%), Forecast, 2011-2020
  • Figure 38: GNI Per Capita ($), Russia, 2005-2010
  • Figure 39: Average Consumer Price Index, Russia, 2005-2010
  • Figure 40: Consumer Price, Russia, Annual Change (%), 2005-2010
  • Figure 41: Average Consumer Price, Russia, Annual Change (%), Forecast, 2011-2020
  • Figure 42: Currency Exchange Rate (RUB/$), Russia, 2005-2010
  • Figure 43: Foreign Direct Investment ($bn), Russia, 2005-2010
  • Figure 44: Foreign Exchange Reserves ($bn), Russia, 2005-2010
  • Figure 45: Imports ($bn), Russia, 2005-2010
  • Figure 46: Exports ($bn), Russia, 2005-2010
  • Figure 47: General Government Structural Balance ($bn), Russia, 2005-2010
  • Figure 48: General Government Structural Balance ($bn), Russia, 2011-2020
  • Figure 49: General Government Gross Debt ($bn), Russia, 2005-2010
  • Figure 50: General Government Gross Debt ($bn), Russia, 2011-2020
  • Figure 51: Major Industries, Russia, Production ($bn), 2010
  • Figure 52: Population (m), Russia, 2005-2010
  • Figure 53: Population (m), Russia, Forecast, 2011-2020
  • Figure 54: Urban and Rural Population, Russia, Share (%), 2005-2010
  • Figure 55: Urban and Rural Population, Russia, Share (%), Forecast, 2011-2020
  • Figure 56: Age Groups, Russia, Population Distribution (%), 2005-2010
  • Figure 57: Age Groups, Russia, Population Distribution (%), Forecast, 2011-2020
  • Figure 58: Births (Per 1,000 Population), Russia, 2005-2010
  • Figure 59: Births (Per 1,000 Population), Russia, Forecast, 2011-2020
  • Figure 60: Mortality (Per 1,000 Population), Russia, 2005-2010
  • Figure 61: Mortality (Per 1,000 Population), Russia, Forecast, 2011-2020
  • Figure 62: Major Causes of Mortality ('000s), Russia, 2008
  • Figure 63: Children <5 Years Age, Russia, Mortality (Per 1,000 Live Births), 2005-2010
  • Figure 64: Immunization Rate (%), Russia, 2005-2010
  • Figure 65: Major Causes of Male Mortality ('000s), Russia, 2008
  • Figure 66: Major Causes of Female Mortality ('000s), Russia, 2008
  • Figure 67: Gender Ratio (M/F), Russia, 2005-2010
  • Figure 68: Life Expectancy at Birth (Years), Russia, 2005-2010
  • Figure 69: Life Expectancy at Birth (Years), Russia, Forecast, 2011-2020
  • Figure 70: Students ('000s), Russia, 2005-2010
  • Figure 71: Unemployment Rate (%), Russia, 2005-2010
  • Figure 72: Employees, Russia, Segment Share (%), 2008
  • Figure 73: Major Diseases, Russia, Incidence ('000s), 2008
  • Figure 74: Major Diseases, Russia, Disability-adjusted Life Years (Per 100,000 Population), 2004
  • Figure 75: Hospitals, Russia, 2005-2010
  • Figure 76: Out-patient Clinics, Russia, 2005-2010
  • Figure 77: Out-patient Clinics, Russia, Urban-Rural, 2005-2010
  • Figure 78: Dental Clinics, Russia, 2005-2010
  • Figure 79: Public Hospitals, Russia, 2005-2010
  • Figure 80: Private Hospitals, Russia, 2005-2010
  • Figure 81: Hospital Beds by Specialization ('000s), Russia, 2010
  • Figure 82: Beds (Per 1,000 Population), Russia, 2005-2010
  • Figure 83: Physicians (Per 1,000 Population), Russia, 2005-2010
  • Figure 84: Physicians by Specialization ('000s), Russia, 2010
  • Figure 85: Deaths Attributed to the Environment (Per 100,000 Population), Russia, 2004
  • Figure 86: Common Air Pollutants (Million Tons), Russia, 2005-2010
  • Figure 87: PM10 (Microgram Per Cubic Meter), Russia, 2005-2010
  • Figure 88: CO2 Emissions (Million Tons), Russia, 2005-2010
  • Figure 89: Organic Water Pollutant Emissions (Metric Tons Per Day), Russia, 2005-2010
  • Figure 90: Healthcare Personnel, Russia, Share (%), 2010
  • Figure 91: Healthcare Expenditure (% of GDP), Russia, 2005-2010
  • Figure 92: Healthcare Expenditure (% of GDP), Russia, 2011-2020
  • Figure 93: Healthcare Expenditure, Russia, Share of Major Components (%), 2007
  • Figure 94: Healthcare Expenditure, Russia, Public-Private Share (%), 2005-2010
  • Figure 95: Opportunities and Challenges, Healthcare Market, Russia, 2012
Back to Top